Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students

NCT07203313 · View on ClinicalTrials.gov ↗

Study Summary

The goal of this clinical trial is to evaluate the newly developed Pocket PE 3-5 app, designed for use by teachers of 3rd-, 4th-, and 5th-grade students. Researchers will compare teachers and students in classrooms using the Pocket PE app with those in classrooms not using the app. The main question it aims to answer is: • Does the use of the Pocket PE 3-5 app improve classroom teacher PE self-efficacy and high-quality PE teaching behaviors, and promote students' moderate-to-vigorous physical activity participation in PE, as well as PE enjoyment and self-efficacy, compared to teachers who do not use Pocket PE 3-5? Participants will: * Randomly use Pocket PE 3-5 (12 intervention schools) for at least one PE class weekly, or not (12 control schools), for 12 consecutive weeks during the 2025/26 school year. * Teachers will complete short surveys at 0 weeks (pre), 6 weeks (mid), and 13 weeks (post). Teachers in the intervention condition will complete a longer survey at 13 weeks (post-intervention) to provide feedback on the Pocket PE app. A random sub-sample of teachers in the intervention condition will be asked to participate in an exit interview to give additional input on Pocket PE 3-5 after the intervention has been completed. * Students will complete brief surveys after PE classes at pre, mid, and post, and will wear wrist heart rate monitors during observed PE classes at these timepoints to measure their physical activity during PE. We will also evaluate the level of implementation of Pocket PE 3-5 among teachers via class observations and objective data collected by the app.

Interventions

  • BEHAVIORAL Digital PE teaching app

Study Locations (2)

Oregon

  • Saavsus, Inc. — Eugene
  • Oregon Research Institute — Springfield

Trial Details

FieldValue
Enrollment Target 1,872 participants
Start Date 2025-09-01
Est. Completion 2026-07
Phase NA

Sponsor

Saavsus

2 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07203313

The ClinicalTrials.gov registry entry for NCT07203313 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,872 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saavsus, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 5 conditions, with Teacher Self-efficacy for Teaching PE appearing as the primary indexed condition, and to 1 intervention — of which Digital PE teaching app is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT07203313 reports 2 study locations spanning 1 distinct geographic area — top geographies include Oregon. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT07203313 about?

NCT07203313 is a clinical study titled "Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students". The goal of this clinical trial is to evaluate the newly developed Pocket PE 3-5 app, designed for use by teachers of 3rd-, 4th-, and 5th-grade students. Researchers will compare teachers and students in classrooms using the Pocket PE app with those in classrooms not using the app. The main questio...

What is the current status of trial NCT07203313?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,872 participants. The study started on 2025-09-01. Estimated completion is 2026-07.

What conditions does trial NCT07203313 study?

This clinical trial studies the following conditions: Teacher Self-efficacy for Teaching PE, Teacher PE Instruction, Student PE Enjoyment, Student Physical Activity, Student PE Satisfaction. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT07203313?

The interventions under investigation include: Digital PE teaching app (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT07203313?

This trial is sponsored by Saavsus, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT07203313 being conducted?

This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial